EUVIMEDEUVIMED entdecken
Crossref

Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K / AKT / NF‐κB signalling pathway

Ziyuan Liu, Huilong Xiang, Qin Deng, Wanting Fu, Yang Li, Zejun Yu, Yinsheng Qiu, Zhinan Mei, Lingyun Xu iD

Nephrology · 2023

DOI: 10.1111/nep.14159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, 2023. Verfasst von Ziyuan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Wuhan Polytechnic University, Wuhan, China. Hauptthemen laut MEDLINE: NF-kappa B, Hyperuricemia. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Hubei Provincial Key Laboratory of Animal Nutrition and Feed Science Open Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Inflammation and apoptosis are main pathological processes that lead to the development of hyperuricemic nephropathy (HN). This study aims to explore whether baicalin (BA) and baicalein (BAI) can relieve the damage through PI3K/AKT/NF‐κB signal pathway and provide more reliable and precise evidence for the treatment of HN.

Methods

HN mice were induced by yeast extract with potassium oxonate (PO), and HK‐2 cells were induced by monosodium urate (MSU). Molecular docking, western blot, q‐PCR, and other methods were used to explore the changes of various indicators in HN mice and HK‐2 cells.

Results

Molecular docking results showed that BA and BAI had good binding ability with PI3K, AKT, p65 and IκBα. BA and BAI significantly ameliorated the levels of renal function, decreased the p‐PI3K, p‐AKT and p‐p65 expression, down‐regulated the BAX/BCL2 and CASP3, and blunted the mRNA levels of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β, and IL‐18 in both renal tissue of HN mice and HK‐2 cells induced by MSU. BA and BAI also decreased the oxidative stress level of MSU‐induced HK‐2 cells.

Conclusion

BA and BAI were confirmed to attenuate HN through alleviating renal inflammatory and apoptosis in cells and tissues by inhibiting PI3K/AKT/NF‐κB pathway. BA and BAI were expected to be developed as new anti‐HN drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BHyperuricemiaMiceAnimalsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesUric AcidMolecular Docking SimulationSignal TransductionInflammationFlavonoidsFlavanones

Stichwörter der Autor:innen

PI3K/AKT/NF-κB pathwaybaicaleinbaicalinhyperuricemic nephropathymonosodium urate

Substanzen

NF-kappa BProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesUric AcidbaicalinFlavonoidsbaicaleinFlavanones

Autor:innen und Institutionen

  • School of Life Science and Technology, Wuhan Polytechnic University, Wuhan, China.
  • School of Animal Science and Nutrition Engineering, Wuhan Polytechnic University, Wuhan, China.
  • School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan, China.

ORCID-Profile: Lingyun Xu

Förderung

  • Hubei Provincial Key Laboratory of Animal Nutrition and Feed Science Open Project
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Z., Xiang, H., Deng, Q., Fu, W., Li, Y., Yu, Z., Qiu, Y., Mei, Z., & Xu, L. (2023). Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K / AKT / NF‐κB signalling pathway. Nephrology. https://doi.org/10.1111/nep.14159

Vancouver

Liu Z, Xiang H, Deng Q, Fu W, Li Y, Yu Z, et al. Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K / AKT / NF‐κB signalling pathway. Nephrology. 2023. doi:10.1111/nep.14159

BibTeX
@article{Liu2023,
  author = {Liu, Ziyuan and Xiang, Huilong and Deng, Qin and Fu, Wanting and Li, Yang and Yu, Zejun and Qiu, Yinsheng and Mei, Zhinan and Xu, Lingyun},
  title = {Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K / AKT / NF‐κB signalling pathway},
  journal = {Nephrology},
  year = {2023},
  doi = {10.1111/nep.14159}
}
Kostenlos starten →